Drug Type Synthetic peptide |
Synonyms |
Target |
Action modulators |
Mechanism 23S rRNA modulators(23S Ribosomal RNA modulators), 50S subunit modulators(50S ribosomal subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC61H60N14O18S5 |
InChIKeyFFLJEMWVYVKPDW-UMNFMQIXSA-N |
CAS Registry214044-52-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Positive Bacterial Infections | Preclinical | United States | 03 Jun 2004 |